Experiences towards hormonal treatments: a qualitative study among endometriosis patients and healthcare professionals

This qualitative study reveals a significant disconnect between endometriosis patients and healthcare professionals regarding the definition of treatment efficacy and communication quality, highlighting the need for improved shared decision-making to address mutual mental burdens and information deficits.

The Gist

The Big Picture: A Broken Compass in a Storm

Imagine endometriosis as a chronic, invisible storm raging inside a woman's body. It causes pain, fatigue, and infertility. Currently, there is no "off switch" (cure) for this storm. The only way to try to calm the waves is with hormonal treatments (like birth control pills or injections), which act like a heavy-duty umbrella.

This study is a conversation between two groups: the patients (the people holding the umbrella in the rain) and the doctors (the people handing out the umbrellas). The researchers wanted to know: Why do these two groups often feel like they are speaking different languages, even when they are trying to solve the same problem?

The Core Conflict: Two Different Maps

The study found a massive disconnect in how the two groups define "success."

• The Doctor's Map (The Long Haul): For the doctors, success looks like stopping the rain entirely. Their main goal is to stop the menstrual cycle completely (amenorrhea). They believe that if you stop the bleeding long-term, the pain will eventually go away. They are playing a marathon game, looking at the finish line years down the road.
• The Patient's Map (The Immediate Shelter): For the patients, success looks like stopping the stinging rain right now. Their main goal is immediate pain relief. They don't care about the long-term theory if they are still in agony today. They are trying to survive the next hour.

The Analogy: It's like a mechanic (doctor) telling a driver (patient), "If you drive this car at 50 mph for 10 years, the engine will be perfect." But the driver is screaming, "I can't even drive 50 feet without the car shaking apart! I need it to run now!"

The "Guinea Pig" Feeling

Because there is no perfect treatment, patients often have to try one hormonal therapy after another. The study revealed that patients feel like guinea pigs in a lab experiment.

• The Trial-and-Error Trap: When a treatment fails or causes terrible side effects (like weight gain, depression, or migraines), patients feel they are just "testing" the next option.
• The Emotional Rollercoaster: Every time they switch meds, they feel a mix of hope ("Maybe this one works!") and dread ("What if this one makes me sicker?").
• The Information Gap: Patients feel the doctors often hand them the umbrella without explaining what's inside it. They aren't told about the potential side effects clearly enough, leaving them feeling unprepared and angry when the "rain" of side effects hits them.

The "Mental Backpack"

One of the most powerful metaphors in the study is the "Mental Backpack."

• For Patients: They carry a heavy backpack filled with the burden of having to research their own disease, find the right doctor, manage their own care, and educate their family. They feel they have to be their own project manager because the medical system feels fragmented.
• For Doctors: They also carry a heavy backpack. It's filled with the emotional weight of listening to complex, painful stories, the frustration of not having a cure, and the exhaustion of long, difficult consultations. They sometimes put on a "professional mask" to protect themselves from being overwhelmed, which patients interpret as coldness or lack of empathy.

The Social Ripple Effect

Endometriosis doesn't just hurt the body; it isolates the person.

• The Invisible Wall: Because the disease is invisible, friends and family often don't understand why the patient is in pain or can't make plans. This leads to loneliness.
• The Relationship Strain: The pain and hormonal changes can kill intimacy and make partners feel helpless or like a burden. Some relationships break because the couple can't navigate the "storm" together.

What's the Solution?

The study concludes that we need to build a Shared Decision-Making Tool. Think of this as a new, shared map that both the doctor and the patient can hold together.

1. Align the Goals: Doctors need to acknowledge that "pain relief today" is just as important as "stopping the cycle for the next decade."
2. Better Communication: Doctors need to listen more and explain the "pros and cons" of the umbrella clearly, so patients aren't surprised by the side effects.
3. Team Effort: Patients shouldn't have to carry the backpack alone. They need their partners, families, and doctors to be part of the team, not just bystanders.

In short: The study says that to fix the management of endometriosis, we need to stop treating it like a simple math problem (A + B = C) and start treating it like a complex human journey where listening, empathy, and shared goals are just as important as the medicine itself.

Technical Summary

1. Problem Statement

Endometriosis is a chronic, estrogen-dependent gynecological disease causing severe pain, infertility, and significant impairment in quality of life and economic productivity. While hormonal therapies are the first-line treatment for pain management, they are increasingly unpopular due to side effects, variable efficacy, and a lack of non-endocrine alternatives.

• The Core Conflict: There is a critical disconnect between patients and healthcare professionals (HCPs) regarding the definition of "treatment efficacy" and the shared decision-making process.
• The Gap: Despite international guidelines advocating for patient engagement, there is limited research comparing the specific perceptions of patients and HCPs regarding hormonal treatment goals, communication barriers, and the resulting mental burden on both parties. This study aims to clarify these discrepancies to improve therapeutic alliances.

2. Methodology

• Study Design: A qualitative cross-sectional study utilizing semi-structured focus groups.
• Participants:
  • Patients (n=20): Women aged 18–50 with confirmed endometriosis (via imaging or surgery) and experience with at least three lines of hormonal therapy.
  • Healthcare Professionals (n=13): Gynecologists and midwives dedicating ≥30% of their practice to endometriosis, many with specialized training or network involvement.
• Data Collection:
  • Patient Focus Groups: Three in-person groups (6–10 participants each) held at a neutral location.
  • Professional Focus Groups: Three online groups (6–10 participants each).
  • Tools: Interview guides structured around four visual aids: effectiveness scales, emotion wheels, metaplans (for relationships), and photolanguage/Wooclap (for environment).
• Patient and Public Involvement (PPI): A patient partner with lived experience of endometriosis acted as a co-investigator, contributing to study design, data collection (co-facilitation), analysis, and interpretation.
• Analysis: Thematic analysis following Braun and Clarke's inductive framework. Transcripts were double-blind coded by 2–3 researchers using Taguette software, with themes validated by the steering committee and patient partners.

3. Key Contributions

• Dual-Perspective Comparison: This is one of the first studies to directly juxtapose the lived experiences of endometriosis patients with the clinical perspectives of specialized HCPs using parallel focus group methodologies.
• Definition of Efficacy: It identifies a fundamental misalignment in how "success" is defined: HCPs prioritize long-term amenorrhea (cessation of menstruation) as a prerequisite for pain relief, whereas patients prioritize immediate pain reduction and psychological well-being.
• Mental Burden Analysis: The study delineates the distinct sources of mental burden: for patients, it stems from the necessity to self-educate and compensate for information deficits; for HCPs, it arises from the resource-intensive nature of managing complex, often "therapeutic impasse" cases.
• PPI Integration: The active role of a patient partner throughout the research lifecycle ensured that findings were grounded in lived reality rather than purely clinical observation.

4. Key Results

A. Divergent Perceptions of Efficacy

• HCP View: Efficacy is defined by achieving long-term amenorrhea, which is believed to suppress disease progression and eventually reduce pain. Treatment changes are driven by therapeutic failure or patient life plans (e.g., pregnancy).
• Patient View: Efficacy is defined by immediate pain relief and the ability to function. Patients view the trade-off between side effects (weight gain, mood disorders, libido loss) and pain relief as often unfavorable. They perceive treatment changes as "being experimented on," leading to anxiety and a sense of being a "guinea pig."

B. Communication and Relational Issues

• Directive vs. Collaborative: While HCPs claim to favor shared decision-making, patients report a directive, hierarchical relationship where their personal goals are ignored.
• Information Deficit: Patients report a lack of empathy and insufficient information regarding side effects and long-term consequences. This forces patients to become self-researchers (via social media/associations), creating a significant mental workload that is not experienced as empowerment but as a survival necessity.
• Trust Erosion: Conflicting messages from different providers and a perceived lack of medical knowledge lead to distrust and anger toward the medical community.

C. Complex Management and Social Impact

• Care Fragmentation: Patients experience disparities in care quality based on geography and facility type. They often find paramedical and alternative practitioners (physiotherapy, psychology) more attentive and effective, though financial barriers limit access.
• Social Isolation: The "invisible" nature of the disease, combined with societal stereotypes, leads to isolation. The disease negatively impacts couple dynamics (sexual dysfunction, infertility guilt) and professional life (inability to meet workplace demands).
• Therapeutic Impasse: Both groups acknowledge the frustration of reaching a point where no further hormonal options seem viable, leading to dissatisfaction and a sense of failure.

5. Significance and Implications

• Reframing Therapeutic Goals: The study argues for revising the definition of therapeutic efficacy to include a timeline that reflects the realities of chronic disease management, prioritizing pain reduction and quality of life alongside (or before) strict amenorrhea goals.
• Shared Decision-Making (SDM) Tool: The authors propose the development of a dedicated SDM tool that includes:
  1. Scientific and educational content for all stakeholders (patients, clinicians, relatives).
  2. A framework for defining common short-, medium-, and long-term objectives.
  3. "Red flags" to prompt care plan reassessment.
• Training and Empathy: There is an urgent need for improved clinician training in communication, empathy, and the management of therapeutic dead ends to reduce the mental burden on both patients and providers.
• Systemic Change: Recognizing the role of the social environment (family, partners) and the need for multidisciplinary support is crucial for holistic care.

Conclusion: The study highlights that the failure of hormonal management in endometriosis is not solely biological but deeply relational. Bridging the gap between the "long-term medical view" and the "immediate patient experience" is essential to restoring trust and improving care outcomes.